Cargando…
Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme
BACKGROUND: CRISPR-Cas13 is a newly emerging RNA knockdown technology that is comparable to RNAi. Among all members of Cas13, CasRx degrades RNA in human cells with high precision and effectiveness. However, it remains unclear whether the efficiency of this technology can be further improved and app...
Autores principales: | Zhan, Yonghao, Cao, Congcong, Li, Aolin, Mei, Hongbing, Liu, Yuchen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843992/ https://www.ncbi.nlm.nih.gov/pubmed/36650600 http://dx.doi.org/10.1186/s13059-023-02852-w |
Ejemplares similares
-
Methods for in vitro CRISPR/CasRx-Mediated RNA Editing
por: Chuang, Yu-Fan, et al.
Publicado: (2021) -
Specific knockdown of Htra2 by CRISPR-CasRx prevents acquired sensorineural hearing loss in mice
por: Guo, Yang, et al.
Publicado: (2022) -
CRISPR/CasRx-Mediated RNA Knockdown Reveals That ACE2 Is Involved in the Regulation of Oligodendroglial Cell Morphological Differentiation
por: Kato, Yukino, et al.
Publicado: (2022) -
Programmable RNA Targeting Using CasRx in Flies
por: Buchman, Anna B., et al.
Publicado: (2020) -
Engineered Extracellular Vesicle‐Delivered CRISPR/CasRx as a Novel RNA Editing Tool
por: Li, Tianwen, et al.
Publicado: (2023)